Clinical Trials Insight: 700029142
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2008
At a glance
- Drugs ADL 5747 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Adolor Corporation; Pfizer
- 01 Mar 2008 Status changed from planning to recruiting as reported by Adolor Corporation.
- 07 Dec 2007 New trial record.